Transformation of sweet orange [Citrus sinensis (L.) Osbeck] with pthA-nls for acquiring resistance to citrus canker disease

Transformation of sweet orange [Citrus sinensis (L.) Osbeck] with pthA-nls for acquiring... The COOH terminal of pthA encoding three nuclear localizing signals (NLS) was amplified by polymerase chain reaction (PCR) from the plasmid of Xanthomonas axonopodis pv. citri, the pathogen of citrus canker disease. Then the sense and antisense strands of the nls were cloned into pBI121 vector. pthA-nls driven by the CaMV35 s promoter was transferred into sweet orange via Agrobacterium -mediated transformation. Successful integration was confirmed by PCR and Southern blotting, and 12 sense-nls (nls +) and 9 antisense-nls (nls −) transgenic clones were obtained. The expression of nls fragment was analyzed by RT–PCR, Real time q-PCR and Western blotting, in which the specific NLS protein was detected only in nls + transgenic clones. In an in vitro assay, when pin-puncture inoculation was performed with 2.5 × 107 cfu/ml of bacterial solution, the nls + transgenic clones showed no typical lesion development, while typical symptoms were observed in the wild types and the nls − transgenic clones. In vivo assay results indicated that the nls + transgenic clones showed less disease incidence, in comparison with the wild types and the nls − transgenic clones, when pin-puncture inoculation was performed with 104–105 cfu/ml. The minimum disease incidence was 23.3% for ‘Sucarri’ sweet orange and 33.3% for ‘Bingtang’ sweet orange. When 104–107 cfu/ml of pathogen was spray inoculated, the nls + transgenic clones did not show any symptom, and even the concentration raised to 109 cfu/ml, the disease incidence was 20–80%, while the wild types and the nls − transgenic clones had 100% disease development with whatever concentration of inoculum. Two transgenic clones were confirmed to be resistant to citrus canker disease in the repeated inoculation. The results suggested that the transformation of nls sense strands may offer an effective way to acquire resistance to citrus canker disease. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Plant Molecular Biology Springer Journals

Transformation of sweet orange [Citrus sinensis (L.) Osbeck] with pthA-nls for acquiring resistance to citrus canker disease

Loading next page...
 
/lp/springer_journal/transformation-of-sweet-orange-citrus-sinensis-l-osbeck-with-ptha-nls-JSSRrQZajj
Publisher
Springer Netherlands
Copyright
Copyright © 2010 by Springer Science+Business Media B.V.
Subject
Life Sciences; Plant Sciences; Plant Pathology; Biochemistry, general
ISSN
0167-4412
eISSN
1573-5028
D.O.I.
10.1007/s11103-010-9699-z
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial